SCHEMBL20536672

SCHEMBL20536672

COC(C/C=C\CCl)OC

nearest known ligand 0.42

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.42
HTT P42858 1/20 0.32
RCE1 Q9Y256 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29621112 0.80 HTT (0.30) HTT
SCHEMBL29621524 0.80 HTT (0.30) HTT
SCHEMBL11539456 0.76 HTT (0.33) HTTRCE1MAPT
SCHEMBL11539460 0.76 HTT (0.33) HTTRCE1MAPT
SCHEMBL9561634 0.74 HTT (0.35) HTTRCE1MAPT
SCHEMBL9561630 0.74 HTT (0.35) HTTRCE1MAPT
SCHEMBL8805069 0.73 TDP1 (0.36) TDP1
SCHEMBL8805063 0.73 TDP1 (0.36) TDP1
SCHEMBL28254931 0.72
SCHEMBL20550244 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108727165-B Process for producing 2, 4-dienal aldehyde compound and 2, 4-dienal compound 信越化学工业株式会社 2021-11-12 CN disclosed
EP-3392230-B1 METHOD FOR PRODUCING 2,4-DIENAL ACETAL COMPOUND AND 2,4-DIENAL COMPOUND SHINETSU CHEMICAL CO (JP) 2020-03-04 EP disclosed
US-10138179-B2 Method for producing 2,4-dienal acetal compound and 2,4-dienal compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-11-27 US disclosed
US-20180305276-A1 METHOD FOR PRODUCING 2,4-DIENAL ACETAL COMPOUND AND 2,4-DIENAL COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-10-25 US disclosed
EP-3392230-A1 METHOD FOR PRODUCING 2,4-DIENAL ACETAL COMPOUND AND 2,4-DIENAL COMPOUND Shin-Etsu Chemical Co., Ltd. (JP) 2018-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10138179-B2 Method for producing 2,4-dienal acetal compound and 2,4-dienal compound SRD5A2, OR51E2, AR TDP1 4610/4885HTT 4754/4885RCE1 99/4885
US-20180305276-A1 METHOD FOR PRODUCING 2,4-DIENAL ACETAL COMPOUND AND 2,4-DIENAL COMPOUND SRD5A2, OR51E2, AR TDP1 4610/4885HTT 4754/4885RCE1 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.